Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleEnfortumab Vedotin Plus Pembrolizumab.AuthorsHanna, Kirollos S.SubjectsTHERAPEUTIC use of antineoplastic agents; BLADDER tumors; PATIENT safety; INVESTIGATIONAL drugs; CANCER patient medical care; UNITED States. Food &; Drug Administration; DRUG approval; METASTASIS; DRUG efficacy; QUALITY assurancePublicationOncology (08909091), 2024, Vol 38, Issue 5, p201ISSN0890-9091Publication typeArticle